» Articles » PMID: 28176421

Incidence and Predictors of Suicide Attempts in Bipolar I and II Disorders: A 5-year Follow-up Study

Overview
Journal Bipolar Disord
Specialty Psychiatry
Date 2017 Feb 9
PMID 28176421
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Few long-term studies on bipolar disorder (BD) have investigated the incidence and risk factors of suicide attempts (SAs) specifically related to illness phases. We examined the incidence of SAs during different phases of BD in a long-term prospective cohort of bipolar I (BD-I) and bipolar II (BD-II) patients, and risk factors specifically for SAs during major depressive episodes (MDEs).

Methods: In the Jorvi Bipolar Study (JoBS), 191 BD-I and BD-II patients were followed using life-chart methodology. Prospective information on SAs of 177 patients (92.7%) during different illness phases was available up to 5 years. The incidence of SAs and their predictors were investigated using logistic and Poisson regression models. Analyses of risk factors for SAs occurring during MDEs were conducted using two-level random-intercept logistic regression models.

Results: During the 5 years of follow-up, 90 SAs per 718 patient-years occurred. The incidence was highest, over 120-fold higher than in euthymia, during mixed states (765/1000 person-years; 95% confidence interval [CI] 461-1269 person-years), and also very high in MDEs, almost 60-fold higher than in euthymia (354/1000 person-years; 95% CI 277-451 person-years). For risk of SAs during MDEs, the duration of MDEs, severity of depression, and cluster C personality disorders were significant predictors.

Conclusions: We confirmed in this long-term study that the highest incidences of SAs occur in mixed and major depressive illness phases. The variations in incidence rates between euthymia and illness phases were remarkably large, suggesting that the question "when" rather than "who" may be more relevant for suicide risk in BD. However, risk during MDEs is likely also influenced by personality factors.

Citing Articles

Lithium and its effects: does dose matter?.

Manchia M, Paribello P, Pinna M, Steardo Jr L, Carpiniello B, Pinna F Int J Bipolar Disord. 2024; 12(1):23.

PMID: 38914810 PMC: 11196441. DOI: 10.1186/s40345-024-00345-8.


Latent Profile Analysis of Suicidal Ideation in Chinese Individuals with Bipolar Disorder.

Pan Y, Wang H, Geng Y, Lai J, Hu S Behav Sci (Basel). 2024; 14(5).

PMID: 38785851 PMC: 11117804. DOI: 10.3390/bs14050360.


NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial.

Nierenberg A, Lavin P, Javitt D, Shelton R, Sapko M, Mathew S Int J Bipolar Disord. 2023; 11(1):28.

PMID: 37573534 PMC: 10423711. DOI: 10.1186/s40345-023-00308-5.


Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.

Morton E, Sakai K, Ashtari A, Pleet M, Michalak E, Woolley J J Psychopharmacol. 2022; 37(1):49-60.

PMID: 36515370 PMC: 9834328. DOI: 10.1177/02698811221131997.


Factors of suicidal behavior among inpatients with major depressive disorder: A retrospective case series.

Liu C, Pan W, Zhu D, Meng F, Tian T, Li L Front Psychiatry. 2022; 13:996402.

PMID: 36213915 PMC: 9537680. DOI: 10.3389/fpsyt.2022.996402.